Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 20/20 | 0.62 |
| ▸ | LCK | P06239 | 4/20 | 0.61 |
| ▸ | LYN | P07948 | 4/20 | 0.61 |
| ▸ | EGFR | P00533 | 6/20 | 0.59 |
| ▸ | TEC | P42680 | 4/20 | 0.59 |
| ▸ | BMX | P51813 | 4/20 | 0.59 |
| ▸ | ITK | Q08881 | 4/20 | 0.59 |
| ▸ | ABL1 | P00519 | 2/20 | 0.59 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.59 |
| ▸ | FYN | P06241 | 2/20 | 0.59 |
| ▸ | YES1 | P07947 | 2/20 | 0.59 |
| ▸ | HCK | P08631 | 2/20 | 0.59 |
| ▸ | FGR | P09769 | 2/20 | 0.59 |
| ▸ | SRC | P12931 | 2/20 | 0.59 |
| ▸ | FER | P16591 | 2/20 | 0.59 |
| ▸ | CSK | P41240 | 2/20 | 0.59 |
| ▸ | BLK | P51451 | 2/20 | 0.59 |
| ▸ | JAK3 | P52333 | 2/20 | 0.59 |
| ▸ | PTK6 | Q13882 | 2/20 | 0.59 |
| ▸ | ERBB4 | Q15303 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6431679 | 0.91 | BTK (0.61) | BTKLCKLYNEGFRTEC | |
| SCHEMBL5802228 | 0.91 | BTK (0.58) | BTKLCKLYNEGFRTEC | |
| SCHEMBL6434693 | 0.90 | BTK (0.64) | BTKLCKLYNEGFRTEC | |
| SCHEMBL5805112 | 0.90 | BTK (0.60) | BTKLCKLYNEGFRTEC | |
| SCHEMBL6430310 | 0.88 | BTK (0.64) | BTKLCKLYNEGFRTEC | |
| SCHEMBL6430574 | 0.85 | BTK (0.66) | BTKLCKLYNEGFRITK | |
| SCHEMBL28901192 | 0.84 | BTK (0.68) | BTKLCKLYNEGFRTEC | |
| SCHEMBL28409287 | 0.83 | BTK (0.73) | BTKLCKLYNEGFRTEC | |
| SCHEMBL28409293 | 0.83 | BTK (0.73) | BTKLCKLYNEGFRTEC | |
| SCHEMBL28409359 | 0.83 | BTK (0.73) | BTKLCKLYNEGFRTEC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020156081-A1 | Pyrazolopyrimidines as therapeutic agents | ABBOTT LABORATORIES (US) | 2002-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156081-A1 | Pyrazolopyrimidines as therapeutic agents | DPYD, CYP2D6, UGT1A1 | BTK 1020/4885LCK 1011/4885LYN 1034/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.